Nobuo Maseki
- Molecular Biology top 5%
- Hematology top 0.5%
- Pathology and Forensic Medicine top 1%
- Oncology top 5%
- Public Health, Environmental and Occupational Health top 2%
- Co-authors
- Yasuhiko KanekoT KozuMisao OhkiM SakuraiMasafumi OhkiMasaharu SakuraiHiroyuki MiyoshiKimiko Shimizu
- Topics
- Acute Myeloid Leukemia Research (34 papers)Lymphoma Diagnosis and Treatment (24 papers)Chronic Lymphocytic Leukemia Research (20 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Nobuo Maseki
86 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Molecular Biology 2.2k
- Hematology 1.9k
- Pathology and Forensic Medicine 886
- Oncology 833
- Public Health, Environmental and Occupational Health 685
Countries citing papers authored by Nobuo Maseki
This map shows the geographic impact of Nobuo Maseki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuo Maseki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuo Maseki more than expected).
Fields of papers citing papers by Nobuo Maseki
This network shows the impact of papers produced by Nobuo Maseki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuo Maseki. The network helps show where Nobuo Maseki may publish in the future.
Co-authorship network of co-authors of Nobuo Maseki
This figure shows the co-authorship network connecting the top 25 collaborators of Nobuo Maseki. A scholar is included among the top collaborators of Nobuo Maseki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuo Maseki. Nobuo Maseki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 45 | |
| 4 | 26 | |
| 5 | 7 | |
| 6 | 27 | |
| 7 | 8 | |
| 8 | 14 | |
| 9 | 14 | |
| 10 | 13 | |
| 11 | 38 | |
| 12 | 35 | |
| 13 | 2 | |
| 14 | 30 | |
| 15 | 47 | |
| 16 | 7 | |
| 17 | 23 | |
| 18 | 70 | |
| 19 | 1 | |
| 20 | 1 |
About Nobuo Maseki
Nobuo Maseki is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 90 papers that have together received 4.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (34 papers), Lymphoma Diagnosis and Treatment (24 papers) and Chronic Lymphocytic Leukemia Research (20 papers). The work is most often cited by research in Hematology (1.9k citations), Pathology and Forensic Medicine (886 citations) and Genetics (479 citations). Nobuo Maseki has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Yasuhiko Kaneko, T Kozu, Misao Ohki, M Sakurai, Masafumi Ohki, Masaharu Sakurai, Hiroyuki Miyoshi, Kimiko Shimizu, N Kamada and Hirofumi Kobayashi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.